MGNX ▲ +0.9% - MacroGenics, Inc.
$MGNX - MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer
26-OCT-2026 07:06 AM ET
Share this post
More filings for $MGNX
MGNX ▼ -1.3% - MacroGenics, Inc.Nov 12, 2026MGNX ▼ -3.9% - MacroGenics, Inc.Nov 5, 2026MGNX ▼ -0.4% - MacroGenics, Inc.Nov 3, 2026MGNX ▲ +0.3% - MacroGenics, Inc.Oct 15, 2026MGNX ▼ -4.6% - MacroGenics, Inc.Sep 9, 2026MGNX - MacroGenics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $MGNX filing history →💬 Comments
Loading comments…
Leave a comment